Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Autor: Wang Y; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dackus GMHE; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Rosenberg EH; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boo LW; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Chan TWS; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong VMT; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Koop E; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Nederlof PM; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van Steenis C; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Salgado RF; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Center, Melbourne, Australia., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.

Publikováno v: BMC medicine [BMC Med] 2024 Jan 09; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2024 Jan 09.

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer: A Review.

Autor: Tarantino, Paolo, Hortobagyi, Gabriel, Tolaney, Sara M., Mittendorf, Elizabeth A.

Publikováno v: JAMA Oncology; Nov2024, Vol. 10 Issue 11, p1578-1584, 7p

Efficacy and safety of different regimens of neoadjuvant therapy in patients with hormone receptor-positive, her2-negative breast cancer: a network meta-analysis.

Autor: Yongxiao Wu, Shibo Huang, Yanlin Wei, Miaoyan Huang, Chunyan Li, Weiming Liang, Tian Qin

Publikováno v: Frontiers in Immunology; 2024, p1-15, 15p

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors.

Autor: Catanzaro E; Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium., Beltrán-Visiedo M; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Galluzzi L; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. deadoc80@gmail.com., Krysko DV; Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. dmitri.krysko@ugent.be.; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium. dmitri.krysko@ugent.be.

Publikováno v: Cellular & molecular immunology [Cell Mol Immunol] 2025 Jan; Vol. 22 (1), pp. 24-39. Date of Electronic Publication: 2024 Dec 10.

Dissecting the immune infiltrate of primary luminal B-like breast carcinomas in relation to age.

Autor: Hatse S; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium., Lambrechts Y; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium., Antoranz Martinez A; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., De Schepper M; Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven, Belgium., Geukens T; Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven, Belgium., Vos H; Department of Surgical Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium., Berben L; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium., Messiaen J; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Marcelis L; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Van Herck Y; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium., Neven P; Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium., Smeets A; Department of Surgical Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium., Desmedt C; Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven, Belgium., De Smet F; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Bosisio FM; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Wildiers H; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium.; Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium., Floris G; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.

Publikováno v: The Journal of pathology [J Pathol] 2024 Nov; Vol. 264 (3), pp. 344-356. Date of Electronic Publication: 2024 Sep 29.